Back to Dashboard
DAWNGBX · Unknown

DAY ONE BIOPHARMACEUTICALS I

USA Unknown Filing: 2025-12-31
Smart-money confidence · 1 of 3 sources firing
Bearish — money moving out

No standout activity across the feeds we track.

Hedge funds
32
Congress
No data
Insiders
No data
Cross-source blend of hedge-fund breadth, Congress trades, and insider Form 4s.  ·  how the score works
◆ Next steps Interested in DAY ONE BIOPHARMACEUTICALS I? Here's what to do with it.
◇ Compare with other stocks Sort 7,111 stocks by confidence, holders, or Congress signal ◈ Backtest the strategy See how the model has done historically before you commit real money ✉ Get the weekly digest One email on Sunday · what changed in the model this week
Not financial advice. Bogen Capital surfaces public SEC filings — you decide what to do with them.
Who's behind the signal
Every informed buyer we can see on DAWNGBX, across all three feeds.
Hedge funds · 6
Point72 (Steve Cohen) New position
Citadel Advisors Increased +105%
Millennium Management (Englander) Increased +95%
Tudor Investment (Paul Tudor Jones) Increased +26%
AQR Capital Management Increased +298%
D.E. Shaw & Co Decreased −72%
Congress · 0
No congressional trades on record.
Insiders
No significant Form 4 insider activity in the window.
Not a model pick — but on our radar. DAY ONE BIOPHARMACEUTICALS I isn't in the top-10 model right now, but 6 tracked investors hold it. Everything below is real signal from public filings — treat this as a watch candidate, not a conviction call.
6
Investors
1
New positions
4
Increasing
1
Decreasing
0
Unchanged
Price History
Loading price data...
Return: High: Low:
Who's Holding This Stock
Position sizes and recent activity from tracked institutional investors
Point72 (Steve Cohen)
Trust weight: 1.1×
New position
% of portfolio
0.0%
Position change
NEW
0.0% of Point72's portfolio
Citadel Advisors
Trust weight: 1.0×
Increased +105%
% of portfolio
0.0%
Position change
+105%
0.0% of Citadel Advisors's portfolio
Millennium Management (Englander)
Trust weight: 1.0×
Increased +95%
% of portfolio
0.0%
Position change
+95%
0.0% of Millennium Management's portfolio
Tudor Investment (Paul Tudor Jones)
Trust weight: 1.2×
Increased +26%
% of portfolio
0.0%
Position change
+26%
0.0% of Tudor Investment's portfolio
AQR Capital Management
Trust weight: 1.0×
Increased +298%
% of portfolio
0.0%
Position change
+298%
0.0% of AQR Capital Management's portfolio
D.E. Shaw & Co
Trust weight: 1.0×
Decreased −72%
% of portfolio
0.0%
Position change
−72%
0.0% of D.E. Shaw & Co's portfolio
Portfolio Allocation
How much of each investor's portfolio is allocated to DAY ONE BIOPHARMACEUTICALS I
⚠ Disclaimer: This page is for informational purposes only. Holdings data from SEC EDGAR 13F filings, delayed up to 135 days. Not a recommendation to buy or sell DAY ONE BIOPHARMACEUTICALS I or any security.

Get the Weekly Update

Every Sunday, we'll send you what Buffett, Dalio, Ackman and 47 other legendary investors are buying — free, straight from their SEC filings.
Free forever · No spam · Unsubscribe anytime
© 2026 Bogen Capital  ·  Not financial advice  ·  Data delayed up to 135 days Methodology  ·  Contact  ·  API